A detailed history of Clearline Capital LP transactions in Accolade, Inc. stock. As of the latest transaction made, Clearline Capital LP holds 237,881 shares of ACCD stock, worth $1.65 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
237,881
Previous 1,539,578 84.55%
Holding current value
$1.65 Million
Previous $5.93 Million 86.28%
% of portfolio
0.12%
Previous 0.26%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

SELL
$3.15 - $4.04 $4.1 Million - $5.26 Million
-1,301,697 Reduced 84.55%
237,881 $813,000
Q3 2024

Nov 14, 2024

BUY
$3.4 - $4.42 $2.41 Million - $3.13 Million
708,794 Added 85.32%
1,539,578 $5.93 Million
Q2 2024

Aug 14, 2024

BUY
$3.58 - $10.13 $2.97 Million - $8.42 Million
830,784 New
830,784 $2.97 Million

Others Institutions Holding ACCD

About Accolade, Inc.


  • Ticker ACCD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 71,938,896
  • Market Cap $499M
  • Description
  • Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and cli...
More about ACCD
Track This Portfolio

Track Clearline Capital LP Portfolio

Follow Clearline Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearline Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Clearline Capital LP with notifications on news.